Sponsor: U.S. Public Health Service, FDA Orphan Products Development
Title: "Iron chelation therapy with desferrioxamine for cerebral malaria"
Project period: 9/94 - 8/97

Sponsor: World Health Organization, Tropical Disease Research Programme
Title: "Arteether therapy for severe malaria in children"
Project period: 7/95 - 8/97

Sponsor: World Health Organization, Tropical Disease Research Programme
Title: "Maternal Recognition of Severe Malaria"
Project period: 7/96 - 6/97

Sponsor: Ajinomoto Co. Inc., Tokyo, Japan
Title: "Evaluation of curdlan sulphate bolus infusion alone and in combination
with quinine in patients infected with malaria"
Project period: 7/96 - 7/2001

Sponsor: ARTECEF, B.V., Maarsen, The Netherlands
Title: "Oral dihydroartemisin for mild to moderate malaria"
Project Period: 10/97 - 7/98

Sponsor: Abbott Diagnostics
Title: "A Field test of a new ELISA-based diagnostic method for P falciparum"
Project period: 10/98 - 10/99

Sponsor: Fulbright Commission, USA
Title: "Epidemiology of Malaria in the Southern Province of Zambia"
Project Period: 11/99 - 6/00

Sponsor: Glaxo-Welcome
Title: "A randomised, double-blind, placebo-controlled trial of atovaquone/proguanil versus sulfadoxine/ pyrimethamine in children with severe plasmodium falciparum malarial anaemia in Zambia".
Project period: 7/00 - 6/02

Sponsor: NIH - NIAID (R01 grant to Howard University)
Title: "Severe Malarial Anemia and Altered Immune Function"
Project Period: 9/00 - 8/05

Sponsor: London School of Hygiene and Tropical Medicine
Title: "Determination of the Entomologic Inoculation Rate (EIR) and the Mosquito Species Involved in P falciparum Transmission in the Macha area of Zambia."
Project Period: 2/02 - 5/02